Machine Learning and Artificial Intelligence for Nanomedicine Optimization

MELINA drives an AI platform in nanomedicine that combines curated data, standardized experimental workflows, and advanced machine learning models to optimize therapeutic nanoparticles. The project integrates information on nanoparticle synthesis, physicochemical characterization, and biological evaluation in cellular models to identify which variables most influence efficacy and safety. It also incorporates high-throughput methods, image analysis, and Quality by Design strategies to guide the development of new formulations in a more systematic and reproducible manner. By reducing trial-and-error and sharing data and tools openly, MELINA aims to accelerate innovation in nanomedicine and strengthen translational research.

Project information

Current

Acronym

MELINA

Start

20/11/2024

End

19/12/2028

Project call

MOMENTUM CSIC 2024

Project reference

MMT24-IQAC-01

Coordinated by IQAC

Yes

Innovation action

No

Total budget

500.727 €

IQAC budget

500.727 €

Principal investigator

Ibane Abasolo Olaortua

Scientific Researcher

Other staff involved

Sergi Vela Llausi

Tenured Scientist